Freestanding Emergency Department Market growth at a CAGR of 6.40% & expected USD 17.56 billion by 2029. It is analyzed as type, application, ownership type and service.

The Non-Cardioselective Beta Blockers Market is expected to grow a healthy CAGR during the forecast period by 2029. It is divided into indication, drugs, target, route of administration, distribution channel and end-user.

Virtual Reality Content Creation Market was valued at USD 23.01 billion in 2023 and is expected to reach USD 501.61 billion, with a CAGR of 47% by 2031.

The Graph Analytics Market was USD 1.14 billion in 2022 and is predicted to grow to USD 7.29 billion by 2030, with a CAGR of 33.82% during the forecast period.

Global Connected Packaging Market, By Technology Used (Active Packaging, Interactive Packaging, Intelligent packaging), End-User (Food, Beverages, Healthcare, Personal Care, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.

Hematology Oncology Market was USD 8.13 billion in 2021, will reach USD 14.83 billion by 2029, and is expected to undergo a CAGR of 7.80% during the forecast period

The anti unmanned aerial vehicle (UAV) defence system market size was USD 2.3 billion in 2023 and it surpasses USD 16.47 billion by 2031, following a CAGR of 27.9%.

Visual Effects Market was USD 10.87 billion in 2023 and is expected to reach USD 19.64 billion by 2031, growing at a CAGR of 7.67% during the forecast period.

Global Leucocytosis Market, By Cause (Infections, Hypoxic Tissue Damage, Trauma, Inflammatory Diseases, Malignancy And Others), Population Type (Children And Adults), Diagnosis (Complete Blood Count, Peripheral Blood Smear, Bone Marrow Biopsy),  Drug Class (Uric Acid Inhibitors, Antibiotics, Anti-Inflammatory, Antihistamines, Others),  Drug Type (Branded And Generics),  Route Of Administration (Oral,  Injectable, And Topical), End User (Hospitals, Specialty Clinics And Others),  Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies And Others),  Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

Metformin Market was USD 4,028 million in 2022 and will reach USD 6,420.02 billion by 2030, and is expected to grow at a CAGR of 6.0% during the forecast period